They found the use of RAAS system inhibitors is not an independent predictor of the Urinary and Plasma ACE2 levels, and their levels could also be influenced by other factors like high blood pressure, liver dysfunction and so on [45]. The gene discussed is ACE2; the disease is Decreased liver function.